Stay updated with breaking news from Oncological Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Breast Cancer Research Foundation (BCRF) has renewed its funding to Elisa Port, MD, and Hanna Irie, MD, PhD, to study new therapeutic approaches that target aggressive triple-negative breast cancer.
Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system.
Research has potential to address significant unmet need, identify biomarkers that determine response to treatmentÂ
Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 grant from Stand Up To Cancer to explore therapeutic approaches to lung tumors with mutations in the KRAS gene, an undertaking that could have a significant impact for a large population of cancer patients who currently lack effective treatment options.
The study, conducted at Mount Sinai, is one of the first to successfully measure T cell responses, which may be able to ensure protection after antibodies are gone.